Buy GLP-1 (SMA) 10mg Research Peptide OnlineGLP-1 (SMA) 10mg Product Specifications & StorageGLP-1 Receptor Agonist Analog (SMA) is an engineered 31-amino-acid peptide designed to provide extended pharmacological activity through structural modifications that enhance proteolytic stability. This compound functions as a selective GLP-1R ligand, enabling preclinical investigation of incretin signaling and metabolic regulation in non-human research environments.GLP-1 (SMA) Mechanism of ActionGLP-1R belongs to the secretin-class G-protein-coupled receptor family and is widely distributed across metabolic and neurological tissues. SMA-design enhancements to native GLP-1 sequence improve plasma half-life while preserving receptor selectivity and agonist potency. In preclinical cellular models, GLP-1 (SMA) activates Gs-coupled signaling, increasing intracellular cAMP and PKA-mediated gene expression. Animal studies demonstrate dose-dependent effects on insulin secretion, glucagon suppression, and gastrointestinal motility through GLP-1R-dependent mechanisms.GLP-1 (SMA) Published Research SummaryPublished research by Fineman et al. (2002) documents the pharmacological profile of extended-release GLP-1 formulations in preclinical models, establishing relationships between dosing kinetics and metabolic response amplitudes. Preclinical studies by Nauck et al. (2001) characterize GLP-1R-dependent effects on nutrient absorption and postprandial glycemic dynamics in animal models. Additional research indicates central GLP-1R activation influences appetite-suppressing neural circuits through hypothalamic and brainstem mechanisms.GLP-1 (SMA) 10mg is formulated as lyophilized powder in research-grade vials. Reconstitute with sterile water or bacteriostatic saline; solutions maintain stability for 48 hours at 4°C. Unreconstituted powder exhibits excellent shelf-life at 2-8°C storage temperature. Proper handling prevents aggregation and maintains biological integrity throughout storage duration.This product is exclusively designated for preclinical research and in vitro laboratory applications. Human administration, clinical investigation, and therapeutic use are strictly prohibited. All research must comply with institutional biosafety guidelines and applicable regulatory requirements.
